Nabla Bio is developing an artificial intelligence-powered drug design platform to engineer next-generation antibody therapeutics and counts George Church, so-called father of synthetic biology, as…
After leading Scorpion Therapeutics through $270 million in financing rounds last year, Gary Glick is back with his fifth startup: Odyssey Therapeutics. Glick’s latest odyssey launches with $218…
The Cambrian explosion refers to an intense burst of growth in life forms on earth during a relatively short time in the Cambrian period, over 500 million years ago. Today, we are witnessing a similar…
Stephanie Jamison Stephanie Jamison has over 15 years of experience in healthcare and health IT public policy. She currently serves as Greenway Health’s Regulatory Affairs Director, a position she has held since January 2019. In this role, she also represents Greenway on the Electronic Health Record Association (EHRA) as a member of the Executive Committee, …
Paddy Padmanabhan Paddy Padmanabhan is the Founder and CEO of Damo Consulting Inc., a digital transformation and growth advisory firm focused on the healthcare sector. He is the author of the best-selling book Healthcare Digital Transformation – How Consumerism, technology and Pandemic are Accelerating the Future. Paddy is a widely published thought leader on technology-led …
Similar to the technology being developed by fellow cancer-focused liquid biopsy developers Grail and Freenome, Harbinger’s platform will use machine learning and other artificial intelligence…
Since ONC is the certifying body for EHRs, providers must be prepared to transition to a new ‘Cures Edition’ version of its software before the end of 2022.
Odyssey Therapeutics is the latest startup formed by serial biotech entrepreneur Gary Glick. Odyssey’s destination is oncology and immunology drugs that address novel disease targets, and the biotech now has $218 million in Series A financing to fuel the journey.
MetaMe received FDA clearance for its first digital therapeutic on Tuesday. It uses behavioral therapy to help alleviate abdominal pain symptoms for patients with irritable bowel syndrome.
Major players in the telehealth space have united to create a supergroup of sorts ahead of a looming lobbying fight.
